Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology

Our incomplete understanding of the link between Alzheimer's Disease pathology and symptomatology is a crucial obstacle for therapeutic success. Recently, translational studies have begun to connect the dots between protein alterations and deposition, brain network dysfunction and cognitive deficits. Disturbance of neuronal activity, and in particular an imbalance in underlying excitation/inhibition (E/I), appears early in AD, and can be regarded as forming a central link between structural brain pathology and cognitive dysfunction. While there are emerging (non-)pharmacological options to influence this imbalance, the complexity of human brain dynamics has hindered identification of an optimal approach. We suggest that focusing on the integration of neurophysiological aspects of AD at the micro-, meso- and macroscale, with the support of computational network modeling, can unite fundamental and clinical knowledge, provide a general framework, and suggest rational therapeutic targets.

Automated summary

Our incomplete understanding of the link between Alzheimer's Disease pathology and symptomatology hinders therapeutic success. Disturbance of neuronal activity, particularly an imbalance in underlying excitation/inhibition (E/I), plays a central role in connecting structural brain pathology and cognitive dysfunction in AD. While there are emerging options to influence this imbalance, the complexity of human brain dynamics complicates identification of an optimal approach.